{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:24:10Z","timestamp":1790288650523,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.schres.2014.03.020","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T12:15:47Z","timestamp":1397650547000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine"],"prefix":"10.1016","volume":"156","author":[{"given":"Kara E.","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogin","family":"Thakore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumlesh K.","family":"Dev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2014.03.020_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR","author":"American Psychiatric Association","year":"1994"},{"issue":"7","key":"10.1016\/j.schres.2014.03.020_bb0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2014.03.020_bb0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269881107075509","article-title":"Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia","volume":"21","author":"Barnett","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.schres.2014.03.020_bb0020","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.schres.2014.03.020_bb0025","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jpsychires.2012.08.016","article-title":"Elevated serum level of type\u20102 cytokine and low IL\u201017 in first episode psychosis and schizophrenia in relapse","volume":"46","author":"Borovcanin","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.schres.2014.03.020_bb0030","doi-asserted-by":"crossref","first-page":"e5197","DOI":"10.1371\/journal.pone.0005197","article-title":"Identification of novel genes and pathways regulating SREBP transcriptional activity","volume":"4","author":"Chatterjee","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.schres.2014.03.020_bb0040","doi-asserted-by":"crossref","first-page":"e59012","DOI":"10.1371\/journal.pone.0059012","article-title":"Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells","volume":"8","author":"Contreras-Shannon","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.schres.2014.03.020_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/oxfordjournals.schbul.a007074","article-title":"Weight gain with clozapine compared to first generation antipsychotic medications","volume":"30","author":"Covell","year":"2004","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2014.03.020_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first\u2010episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.schres.2014.03.020_bb0050","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"Nacetylcysteine for antioxidant therapy: pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.schres.2014.03.020_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.schres.2014.03.020_bb0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2014.03.020_bb0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2012.110","article-title":"Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"8","author":"Fillman","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2014.03.020_bb0075","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.schres.2014.03.020_bb0080","first-page":"109","article-title":"Selected cytokines (Il\u20106, Il\u20108, Il\u201010, MCP\u20101, TNF\u2010alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes","volume":"56","author":"G\u0142owi\u0144ska","year":"2003","journal-title":"Wiad. Lek."},{"issue":"7321","key":"10.1016\/j.schres.2014.03.020_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.schres.2014.03.020_bb0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145709009924","article-title":"A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder","volume":"12","author":"Khairova","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2014.03.020_bb0095","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/schbul\/sbr031","article-title":"Schizophrenia genetics: where next?","volume":"37","author":"Kim","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2014.03.020_bb0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mehy.2009.09.040","article-title":"A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction","volume":"74","author":"Kinney","year":"2010","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.schres.2014.03.020_bb0105","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.2337\/diabetes.54.suppl_2.S114","article-title":"Interleukin\u20106 and diabetes: the good, the bad, or the indifferent?","volume":"54","author":"Kristiansen","year":"2005","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.schres.2014.03.020_bb0110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2014.03.020_bb0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/PSY.0b013e3182a3d91f","article-title":"Infection load as a predisposing factor for somatoform disorders: evidence from a Dutch General Practice Registry","volume":"75","author":"Lacourt","year":"2013","journal-title":"Psychosom. Med."},{"issue":"7","key":"10.1016\/j.schres.2014.03.020_bb0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2014.03.020_bb0125","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1586\/14737175.6.7.1017","article-title":"Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders","volume":"6","author":"M\u00fcller","year":"2006","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.schres.2014.03.020_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00406-008-2012-3","article-title":"A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders","volume":"258","author":"M\u00fcller","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2014.03.020_bb0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"M\u00fcller","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2014.03.020_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1192\/bjp.183.3.197","article-title":"Clinical interventions for treatment non-adherence in psychosis: meta-analysis","volume":"183","author":"Nos\u00e9","year":"2003","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2014.03.020_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-244X-13-146","article-title":"Levels of S100B are raised in female patients with schizophrenia","volume":"13","author":"O'Connell","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2014.03.020_bb0150","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"7","key":"10.1016\/j.schres.2014.03.020_bb0155","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s00125-011-2088-6","article-title":"Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: action LADA 4","volume":"54","author":"Pham","year":"2011","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.schres.2014.03.020_bb0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-3956(00)00032-7","article-title":"Effects of antipsychotic drugs on cytokine networks","volume":"34","author":"Pollmacher","year":"2000","journal-title":"J. Psychiatry Res."},{"issue":"8","key":"10.1016\/j.schres.2014.03.020_bb0165","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2014.03.020_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","article-title":"Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?","volume":"140","author":"R\u00f8ge","year":"2012","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2014.03.020_bb0180","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/mp.2011.42","article-title":"Identification of a biological signature for schizophrenia in serum","volume":"17","author":"Schwarz","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"A","key":"10.1016\/j.schres.2014.03.020_bb0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2013.06.025","article-title":"Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways","volume":"76","author":"Shrestha","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2014.03.020_bb0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuro.2009.03.004","article-title":"The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?","volume":"30","author":"Soczynska","year":"2009","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.schres.2014.03.020_bb0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/CCLM.2011.083","article-title":"S100B protein in neurodegenerative disorders","volume":"49","author":"Steiner","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.schres.2014.03.020_bb0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"33","author":"Sugino","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2014.03.020_bb0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2014.03.020_bb0215","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1192\/bjp.181.3.184","article-title":"Clozapine-resistant schizophrenia: a positive approach","volume":"181","author":"Williams","year":"2002","journal-title":"Br. J. Psychiatry"},{"issue":"18","key":"10.1016\/j.schres.2014.03.020_bb0220","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.schres.2014.03.020_bb0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin\u20106 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996414001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996414001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T22:23:30Z","timestamp":1538691810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996414001467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0920996414001467"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2014.03.020","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2014.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}